Photonanomedicine for Cancer: A nanotechnology-based advancement in photodynamic therapy

Nooreen Ali Nizami1, Km Rafiya1, Nazeer Hasan2

  • 1Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi 110062, India.

Insights

Photodynamic therapy (PDT) is a minimally invasive cancer treatment. Nanotechnology enhances PDT agents, improving selectivity, stability, and reactive oxygen species (ROS) production for better cancer cell destruction.

Area of Science:

  • Oncology
  • Biotechnology
  • Nanomedicine

Background:

  • Photodynamic therapy (PDT) is a minimally invasive cancer treatment utilizing photosensitizers and light to generate reactive oxygen species (ROS) for cancer cell death.
  • Conventional PDT faces limitations including poor hydrophilicity, aggregation, and insufficient ROS generation, hindering its clinical efficacy.
  • Nanotechnology offers a promising solution to overcome these limitations, developing advanced photosensitizers for improved cancer therapy.

Purpose of the Study:

  • To review the evolution of photodynamic therapy (PDT) from conventional methods to nanotechnology-based approaches.
  • To discuss the advancements in selectivity, stability, ROS production, and the enhanced permeability and retention (EPR) effect of nano-PDT agents.
  • To highlight recent developments, mechanisms, advantages, nano-photosensitizers, and applications of nanotechnology-based PDT in various cancers.

Main Methods:

  • Comparative analysis of conventional PDT versus nanotechnology-based PDT.
  • Review of recent scientific literature on nano-photosensitizers and their properties.
  • Discussion of the mechanism of action and therapeutic advantages of advanced PDT strategies.

Main Results:

  • Nanotechnology significantly improves PDT agent characteristics, including solubility, stability, and targeted delivery.
  • Nano-PDT demonstrates enhanced ROS production and improved tumor selectivity compared to conventional PDT.
  • The enhanced permeability and retention (EPR) effect is leveraged by nano-PDT for improved accumulation in tumor tissues.

Conclusions:

  • Nanotechnology-based PDT represents a significant advancement over conventional PDT, offering improved therapeutic outcomes.
  • Nano-photosensitizers provide enhanced efficacy, reduced side effects, and overcome limitations of traditional PDT agents.
  • Further research and clinical translation of nanotechnology-based PDT hold great promise for effective cancer treatment.